During transitions between medications, blood sugar levels can become unpredictable
If obesity causes both type 2 diabetes and hypothyroidism, treating the obesity with semaglutide to lose weight could help reduce the impact or even "cure" both hypothyroidism and diabetes while addressing obesity
In recent years, the therapeutic footprint of this class has grown: long-acting agents (e.g., liraglutide, semaglutide) and next-generation dual/triple agonists (e.g., tirzepatide) have demonstrated superior glycemic control, weight reduction, and cardiovascular benefits in adults with T2DM (Yao et al., 2024)
Customised dosing: The compounded nature allows for tailored strength and individualisation depending on the patients response and tolerability
Cell Metab (2014) 20:799812
I wanted to see just how significant a physical difference the GPL1 medication has had on my body and lipoedema